PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Anne de la RochefordiereSuzy M Scholl

Abstract

EGFR is frequently overexpressed in cervical cancer, suggesting EGFR blockade as a promising treatment approach. Cetuximab, an anti EGFR antibody, used conjointly with radiochemotherapy, was feasible in first-line treatment of cervix carcinoma limited to the pelvis. This randomized phase II trial enrolled 78 FIGO stage IB2-IIIB cervical cancer patients to either cisplatin-based radiochemotherapy alone (arm B, n = 38) or conjointly with a 6-week course of weekly cetuximab (arm A, n = 40). Brachytherapy was given to the pelvic mass. Primary endpoint was disease-free survival (DFS) at 2 years. EGFR expression and targeted sequencing were performed in 54 of 78 patients. Cetuximab over a 6-week period did not improve DFS at 24 months. At 31 months median follow-up, DFS was not significantly different (P = 0.18). Complete response at 4 to 6 months was strongly predictive for excellent DFS (log-rank test; P < 0.001). PIK3CA, KRAS, and STK11 mutations were observed in 22%, 4%, and 2% of patients, respectively. No tumor with a PI3K pathway mutation showed complete response (0/8 in arm A and 0/6 in arm B), whereas 14 of 52 (27%) tumors without mutations did (P = 0.021). PI3K pathway-mutated tumors showed a trend toward poorer DFS (P = 0....Continue Reading

References

Apr 15, 1999·The New England Journal of Medicine·P G RoseS Insalaco
Oct 24, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H Arias-PulidoC F Verschraegen
Aug 2, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F PerroneS Pilotti
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Nov 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maartje G NoordhuisAte G J van der Zee
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B Vermorken, P Specenier
Jun 10, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ingeborg TinhoferUlrich Keilholz
Jul 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Qing ZhouYi-Long Wu
Jan 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julie K SchwarzPerry W Grigsby
Dec 26, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lisa LicitraFortunato Ciardiello
Sep 17, 2013·Journal of Surgical Oncology·Xiaoli ZhuXingming Chen
Dec 18, 2013·International Journal of Radiation Oncology, Biology, Physics·Tracey SchefterUNKNOWN Radiation Therapy Oncology Group (RTOG)
Dec 18, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jean-Louis PujolNick Thatcher
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Kian AngRita S Axelrod

❮ Previous
Next ❯

Citations

Feb 22, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I TinhoferUNKNOWN DKTK-ROG
Feb 3, 2016·Virchows Archiv : an International Journal of Pathology·Diána BrauswetterIstván Peták
Dec 3, 2015·Current Opinion in Obstetrics & Gynecology·Alfonso Dueñas-González, Sergio Campbell
Sep 12, 2015·Scientific Reports·Libing XiangHuijuan Yang
Feb 28, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ebubekir DiricanAyşe Özer
Nov 5, 2015·BMC Cancer·Charlotte NgoUNKNOWN RAIDs consortium http://www.raids-fp7.eu/
Dec 7, 2016·British Journal of Cancer·Christopher M JonesDuncan C Gilbert
Nov 3, 2016·Therapeutic Advances in Gastroenterology·Marina De RosaPaolo Delrio
Nov 17, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Satoru SagaeUNKNOWN Gynecologic Cancer InterGroup Cervix Cancer brainstorming day
May 31, 2017·Cancer Medicine·Robert F KoncarNooshin Hashemi Sadraei
Nov 21, 2019·Journal of the National Cancer Institute·Brian T BeatyBhishamjit S Chera
May 16, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cyrus ChargariEric Deutsch
Jun 18, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hong LouMichael Dean
Sep 22, 2020·Gynecologic Oncology·Yuya YoshimotoTakashi Nakano
Mar 20, 2021·BMC Cancer·Shahana SharminMahmuda Yasmin
Aug 31, 2021·Seminars in Radiation Oncology·Shivani SudColette J Shen
Aug 31, 2021·Seminars in Radiation Oncology·Brian T BeatyAshley A Weiner
Jan 22, 2020·International Journal of Radiation Oncology, Biology, Physics·Laura BourillonCéline Bourgier

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
N Zamboglou, T Schnabel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Barbara BurtnessEastern Cooperative Oncology Group
Expert Review of Anticancer Therapy
F RiveraLourdes Gutiérrez-Sanz
© 2022 Meta ULC. All rights reserved